Rankings
▼
Calendar
ARGX Q4 2017 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$45B
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$16M
+61.4% YoY
Gross Profit
-$9M
-53.4% margin
Operating Income
-$19M
-118.2% margin
Net Income
-$20M
-121.0% margin
EPS (Diluted)
$-0.72
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$21M
Stock-Based Comp.
$19M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$16M
$10M
+61.4%
Gross Profit
-$9M
-$10M
+13.2%
Operating Income
-$19M
-$15M
-31.1%
Net Income
-$20M
-$14M
-41.8%
← Q2 2017
All Quarters
Q2 2018 →